REVIEW
|
doi:10.20944/preprints202104.0105.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Sedaghatian-type Spondylometaphyseal Dysplasia; SSMD; glutathione peroxidase 4; GPX4; rare genetic disorder; therapy development; roadmap; ultra-rare disease
Online: 5 April 2021 (11:57:03 CEST)